Skip to main content
Clinical Trials/NCT06504056
NCT06504056
Not Yet Recruiting
N/A

Risk Stratification and Early Prevention Strategies for Non-compaction of Ventricular Myocardium (CAPTAIN): a Multicenter, Retrospective-prospective, Cohort Study

First Affiliated Hospital Xi'an Jiaotong University1 site in 1 country2,000 target enrollmentOctober 30, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Isolated Noncompaction of the Ventricular Myocardium
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Enrollment
2000
Locations
1
Primary Endpoint
Change in the incidence of mortality rate
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

This study intends to retrospectively-prospectively enroll NVM patients from multiple centers to establish a natural population cohort of NVM patients. By collecting clinical data and biological samples from surgical patients, the investigators will construct a prognosis prediction system for NVM, optimize risk stratification, explore new strategies for the early prevention and treatment of NVM, and improve the efficiency of clinical treatment of NVM patients.

Detailed Description

This study intends to retrospectively-prospectively enroll NVM patients from multiple centers to establish a natural population cohort of NVM patients. By collecting clinical data and biological samples from surgical patients, the investigators will construct a prognosis prediction system for NVM, optimize risk stratification, explore new strategies for the early prevention and treatment of NVM, and improve the efficiency of clinical treatment of NVM patients.

Registry
clinicaltrials.gov
Start Date
October 30, 2024
End Date
September 1, 2030
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • The diagnosis of nvm was confirmed by cardiac ultrasound, electrocardiogram, magnetic resonance angiography, pathological examination and gene sequencing.
  • Patients or their families agreed to participate in the study and authorized informed consent.

Exclusion Criteria

  • Incomplete clinical data.
  • Do not agree to the inclusion or refuse to authorize the informed consent.

Outcomes

Primary Outcomes

Change in the incidence of mortality rate

Time Frame: At diagnosis, before discharge (about 7 days), 1, 3, 6, 9 month, 1, 2, 3 year.

The survival status will be obtained from the medical records and phone calls to patients or their family members.

Study Sites (1)

Loading locations...

Similar Trials